{
  "id": 20342101,
  "title": "Wegovy Reduces BMI in Kids With Obesity as Young as 6",
  "url": "https://urgent.news/2026/11/16/wegovy-reduces-bmi-in-kids-with-obesity-as-young-as-6",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T21:47:48.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/obesityweek/123910"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. At week 68, mean body...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "CNBC",
        "title": "Novo says Wegovy injection lowers BMI and obesity rates in children in trial",
        "url": "https://urgent.news/2026/11/16/novo-says-wegovy-injection-lowers-bmi-and-obesity-rates-in-children",
        "published": "2026-11-16T15:00:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}